Alexander Stephan Noguerola

Array ( [id] => 10762226 [patent_doc_number] => 20160108379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-21 [patent_title] => 'ACTRIIB-FC POLYNUCLEOTIDES, POLYPEPTIDES, AND COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 14/836684 [patent_app_country] => US [patent_app_date] => 2015-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 23245 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14836684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10981687 [patent_doc_number] => 20160178631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-23 [patent_title] => 'METHODS FOR THE EARLY DETECTION OF COLORECTAL CANCER' [patent_app_type] => utility [patent_app_number] => 14/832441 [patent_app_country] => US [patent_app_date] => 2015-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 68819 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 42 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14832441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10574384 [patent_doc_number] => 09297012 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-29 [patent_title] => 'Methods and compositions for inducing deregulation of EPHA7 and ERK phosphorylation in human acute leukemias' [patent_app_type] => utility [patent_app_number] => 14/829057 [patent_app_country] => US [patent_app_date] => 2015-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 19951 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14829057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11993978 [patent_doc_number] => 20170298133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'A method of treating bone metastasis diseases, medicaments therefore, and a method of predicting the clinical outcome of treating bone metastasis diseases' [patent_app_type] => utility [patent_app_number] => 15/511959 [patent_app_country] => US [patent_app_date] => 2015-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 12826 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15511959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10468996 [patent_doc_number] => 20150354013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-10 [patent_title] => 'DETECTING NEOPLASM' [patent_app_type] => utility [patent_app_number] => 14/827013 [patent_app_country] => US [patent_app_date] => 2015-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15339 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14827013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11004185 [patent_doc_number] => 20160201135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-14 [patent_title] => 'NOVEL ESTROGEN RECEPTOR MUTATIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/820217 [patent_app_country] => US [patent_app_date] => 2015-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 50402 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14820217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14145491 [patent_doc_number] => 10253104 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-09 [patent_title] => Bispecific antibodies against CD3[?] and BCMA [patent_app_type] => utility [patent_app_number] => 15/501620 [patent_app_country] => US [patent_app_date] => 2015-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 35 [patent_no_of_words] => 48989 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15501620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12002151 [patent_doc_number] => 20170306305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'NON-FUCOSYLATED PROTEIN AND METHODS THEREOF' [patent_app_type] => utility [patent_app_number] => 15/500509 [patent_app_country] => US [patent_app_date] => 2015-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 23448 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15500509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15851129 [patent_doc_number] => 10640830 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-05 [patent_title] => Drug selection for non-small cell lung cancer therapy [patent_app_type] => utility [patent_app_number] => 14/812979 [patent_app_country] => US [patent_app_date] => 2015-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 35 [patent_no_of_words] => 20915 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 255 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14812979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17323837 [patent_doc_number] => 11214836 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-04 [patent_title] => Methods and devices for predicting anthracycline treatment efficacy [patent_app_type] => utility [patent_app_number] => 15/325472 [patent_app_country] => US [patent_app_date] => 2015-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9373 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15325472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13746759 [patent_doc_number] => 10166304 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-01 [patent_title] => Antibody fragments for detecting cancer and methods of use [patent_app_type] => utility [patent_app_number] => 15/325696 [patent_app_country] => US [patent_app_date] => 2015-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 37 [patent_no_of_words] => 21822 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15325696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10414295 [patent_doc_number] => 20150299306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-22 [patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATION OF OLFML3 MEDIATED ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 14/793065 [patent_app_country] => US [patent_app_date] => 2015-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 24772 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14793065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10799534 [patent_doc_number] => 20160145691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-26 [patent_title] => 'NOVEL ESTROGEN RECEPTOR MUTATIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/753397 [patent_app_country] => US [patent_app_date] => 2015-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 61190 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14753397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10405299 [patent_doc_number] => 20150290308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'MONOCLONAL ANTIBODIES FOR CSPG4 FOR THE DIAGNOSIS AND TREATMENT OF BASAL BREAST CARCINOMA' [patent_app_type] => utility [patent_app_number] => 14/748123 [patent_app_country] => US [patent_app_date] => 2015-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 27562 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14748123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13151881 [patent_doc_number] => 10092645 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-09 [patent_title] => Methods of treatment with antagonists against PD-1 and PD-L1 in combination with radiation therapy [patent_app_type] => utility [patent_app_number] => 14/740876 [patent_app_country] => US [patent_app_date] => 2015-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 34 [patent_no_of_words] => 10245 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14740876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13182235 [patent_doc_number] => 10106620 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-23 [patent_title] => Blocking CD38 using anti-CD38 F(ab')2 to protect NK cells [patent_app_type] => utility [patent_app_number] => 15/319344 [patent_app_country] => US [patent_app_date] => 2015-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 47 [patent_no_of_words] => 12757 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15319344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11025507 [patent_doc_number] => 20160222458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-04 [patent_title] => 'Gene Expression Profile Breast Tumour Grading' [patent_app_type] => utility [patent_app_number] => 14/737807 [patent_app_country] => US [patent_app_date] => 2015-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 86 [patent_figures_cnt] => 86 [patent_no_of_words] => 74697 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14737807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10461189 [patent_doc_number] => 20150346204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-03 [patent_title] => 'MEK Mutations Conferring Resistance to MEK Inhibitors' [patent_app_type] => utility [patent_app_number] => 14/735973 [patent_app_country] => US [patent_app_date] => 2015-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 38160 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14735973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10367434 [patent_doc_number] => 20150252439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'Methods and Compositions for Prostate Cancer Metastasis' [patent_app_type] => utility [patent_app_number] => 14/717248 [patent_app_country] => US [patent_app_date] => 2015-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16150 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14717248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10374411 [patent_doc_number] => 20150259417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-17 [patent_title] => 'Anti-Glypican 3 Antibody' [patent_app_type] => utility [patent_app_number] => 14/713416 [patent_app_country] => US [patent_app_date] => 2015-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 30589 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14713416 [rel_patent_id] =>[rel_patent_doc_number] =>)